{"gene":"NACC1","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1997,"finding":"NAC1 (NACC1) was identified as a novel transcript in rat nucleus accumbens encoding a protein with a POZ/BTB domain in its first 120 amino acids, and its mRNA levels were increased ~50% in nucleus accumbens 3 weeks after cocaine self-administration, establishing it as a cocaine-regulated gene in the brain.","method":"In situ transcription-PCR, in situ hybridization, Northern blot, cDNA cloning","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — original discovery paper with multiple methods; independently replicated in subsequent studies","pmids":["9278521"],"is_preprint":false},{"year":2000,"finding":"NAC1 acts as a transcriptional repressor localized to the nucleus of neurons; it represses reporter gene transcription and interacts with other POZ/BTB proteins via its POZ/BTB domain in mammalian two-hybrid studies; adenoviral overexpression of NAC1 in rat nucleus accumbens prevented development (but not expression) of cocaine-induced behavioral sensitization.","method":"Nuclear localization imaging, Gal4-luciferase reporter assay, mammalian two-hybrid, adenoviral overexpression in vivo","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (reporter assay, two-hybrid, in vivo functional test); foundational paper","pmids":["10934270"],"is_preprint":false},{"year":2002,"finding":"Two NAC1 isoforms (sNAC1 and lNAC1, differing by 27 amino acids) both repress transcription in HEK293T cells, but the shorter isoform represses less effectively; both show subnuclear punctate localization; cocaine transiently increases sNAC1 levels in the nucleus accumbens 2 h after acute injection.","method":"cDNA cloning, Western blot, Gal4-luciferase reporter assay, immunofluorescence, semi-quantitative RT-PCR","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in a single study","pmids":["11906783"],"is_preprint":false},{"year":2003,"finding":"The mouse Nac1 gene contains a functional AP1 binding site in an intron 1 enhancer; co-transfection with c-jun/c-fos activated the wild-type enhancer, and mutation of the AP1 site abrogated activation, establishing AP1 as a transcriptional regulator of Nac1.","method":"Promoter-reporter (luciferase), site-directed mutagenesis, co-transfection","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis and reporter assay confirm AP1 regulation","pmids":["14521994"],"is_preprint":false},{"year":2005,"finding":"NAC1 interacts with HDAC3 and HDAC4 via both its POZ domain and non-POZ regions; HDAC inhibition reverses NAC1-mediated transcriptional repression in neuronal-like cultures; NAC1 does not interact with NCoR, SMRT, or mSin3a, indicating selectivity for HDAC3/4 as corepressors.","method":"Co-immunoprecipitation, GST pulldown, mammalian two-hybrid, Gal4-luciferase reporter assay","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal Co-IP, GST pulldown, and functional reporter assay with HDAC inhibitor validation","pmids":["16033423"],"is_preprint":false},{"year":2005,"finding":"NAC1 subcellular localization is activity-dependent: phosphorylation of residue S245 by PKC is necessary for diffuse cytoplasmic localization outside the nucleus in differentiated neurons; tetrodotoxin blocks and high-K+ depolarization induces this diffuse distribution.","method":"PKC inhibitors/activators, systematic PKC-site mutagenesis, immunofluorescence in primary cortical neurons and differentiated PC12/Neuro2A cells","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis of specific phosphorylation site combined with pharmacological evidence","pmids":["16045493"],"is_preprint":false},{"year":2006,"finding":"NAC1 forms discrete nuclear bodies via homodimerization through the BTB/POZ domain; expression of a BTB/POZ-only dominant-negative disrupts these nuclear bodies, prevents tumor formation, and promotes apoptosis in cancer xenografts.","method":"Co-immunoprecipitation, double immunofluorescence, mouse xenograft model with dominant-negative expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, imaging, and in vivo functional validation with dominant-negative; replicated in subsequent studies","pmids":["17130457"],"is_preprint":false},{"year":2007,"finding":"NAC1 negatively regulates transcription of Gadd45GIP1; NAC1 knockdown in SKOV3 and HeLa cells induces Gadd45GIP1 expression, while engineered NAC1 expression suppresses it; Gadd45GIP1 induction partially mediates NAC1 knockdown-induced growth arrest.","method":"SAGE, siRNA knockdown, ectopic NAC1 expression, luciferase reporter, in vitro and in vivo growth assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (gain/loss of function, SAGE, in vivo) in a single paper","pmids":["17804717"],"is_preprint":false},{"year":2007,"finding":"NAC1 complexes with proteins in the ubiquitin-proteasome system (cullins, Mov34) and co-translocates with the proteasome from the nucleus into dendritic spines in cortical neurons in response to proteasome inhibition or disinhibiting synaptic activity (bicuculline); NAC1-deficient neurons fail to recruit the proteasome into dendritic spines and postsynaptic density.","method":"Co-immunoprecipitation, immunofluorescence, subcellular fractionation, Nac1 knockout neurons, dominant-negative NAC1 lacking proteasome-binding domain","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, imaging, genetic KO, and dominant-negative all converge on same mechanism","pmids":["17699672"],"is_preprint":false},{"year":2007,"finding":"NAC1 interacts with CoREST via its POZ/BTB domain; this interaction is detected by co-immunoprecipitation in neuro-2A, HEK293T cells, and rat brain lysates; POZ/BTB homodimerization is not required for NAC1-CoREST interaction; siRNA-mediated NAC1 knockdown reverses CoREST-mediated transcriptional repression.","method":"Co-immunoprecipitation, GST pulldown, siRNA knockdown, luciferase reporter assay, endogenous brain protein interaction","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, GST pulldown, functional reporter, and endogenous brain validation","pmids":["17254023"],"is_preprint":false},{"year":2008,"finding":"NAC1 functions as a corepressor for multiple other POZ/BTB proteins (ZID, BCL6, ZF5, MAYVEN, NRP/B, BCoR) via its POZ/BTB domain; NAC1 does not interact with PLZF; endogenous NAC1 and BCL6 are physically associated in CNS regions.","method":"Mammalian two-hybrid, GST pulldown, co-immunoprecipitation from brain lysates, Gal4-reporter assay","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 — multiple protein-protein interaction methods with endogenous validation","pmids":["19121354"],"is_preprint":false},{"year":2009,"finding":"NAC1 homodimerization contributes to paclitaxel resistance in ovarian cancer by negatively regulating the Gadd45 pathway; disruption of NAC1 homodimerization by dominant-negative BTB/POZ domain or siRNA knockdown induces Gadd45γ, which interacts with Gadd45gip1 to increase paclitaxel sensitivity.","method":"siRNA knockdown, dominant-negative expression, ectopic expression, cell viability assays, ex vivo tissue correlation","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — gain and loss of function with defined downstream pathway; replicated across cell lines and tissue","pmids":["19305429"],"is_preprint":false},{"year":2009,"finding":"The C-terminal pentapeptide WNAAP of Nanog's tryptophan repeat domain is sufficient for binding Nac1; Nanog and Nac1 synergistically upregulate ERas expression and promote ES cell proliferation via the PI3K/Akt pathway, while the Nanog-Nac1 interaction regulates cell cycle but not pluripotency.","method":"Gal4-DBD fusion co-immunoprecipitation, cell cycle analysis, Akt phosphorylation assay, luciferase reporter","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in one study but single lab","pmids":["19366700"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of the human Nac1 POZ domain at 2.1 Å resolution shows it crystallizes as a dimer with interaction interfaces resembling POZ-zinc finger transcription factors; the C-terminal alpha-helix is shorter than most other POZ domains.","method":"X-ray crystallography","journal":"Acta crystallographica Section F","confidence":"High","confidence_rationale":"Tier 1 — crystal structure determination","pmids":["19407373"],"is_preprint":false},{"year":2011,"finding":"NAC1 autophagy regulation is mediated by HMGB1: NAC1 increases HMGB1 expression, cytosolic translocation, and release; the resulting cytoplasmic HMGB1 activates autophagy; NAC1 knockdown or dominant-negative expression suppresses cisplatin-induced autophagy and increases cytotoxicity.","method":"siRNA knockdown, dominant-negative expression, Western blot, HMGB1 translocation imaging, autophagy inhibitors (3-MA, chloroquine), Beclin1/Atg5 siRNA","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple pharmacological and genetic approaches converge on HMGB1-mediated autophagy pathway","pmids":["21743489"],"is_preprint":false},{"year":2011,"finding":"NAC1 nuclear bodies undergo cell cycle-dependent dynamics: they increase in number and decrease in size in S phase, disappear during mitosis, and reappear after mitosis; FRAP shows rapid exchange of NAC1 between nucleoplasm and nuclear bodies in interphase.","method":"Fluorescence recovery after photobleaching (FRAP), live-cell imaging, cell cycle synchronization","journal":"Physical biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct live-cell imaging with FRAP, single lab","pmids":["21301057"],"is_preprint":false},{"year":2012,"finding":"NAC1 functions as an actin monomer-binding protein via its BTB domain; disruption of NAC1 by dominant-negative or siRNA reduces cell retraction and abscission during cytokinesis, causing multinucleation; NAC1 modulates the binding of actin to profilin-1, and the NAC1/actin/profilin-1 complex is crucial for cancer cell cytokinesis.","method":"Actin-binding assay, siRNA knockdown, dominant-negative expression, rescue in Nac1-deficient murine fibroblasts, multinucleation phenotype quantification","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — direct actin binding demonstrated, genetic rescue experiment, multiple cell line validation","pmids":["22761335"],"is_preprint":false},{"year":2012,"finding":"NAC1 nuclear localization requires a bipartite NLS in the N-terminal half of the protein that functions through the importin α/β pathway; dimer formation is not required for nuclear localization; the NLS is essential for NAC1's transcriptional regulatory function.","method":"Point mutagenesis, deletion mutant analysis, GFP-fusion nuclear import assay, Bimax1 peptide inhibitor of importin α/β pathway, importin binding assay","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis, pharmacological inhibition, and direct binding assay","pmids":["22665369"],"is_preprint":false},{"year":2013,"finding":"Loss of NAC1 in Nacc1−/− mice causes vertebral patterning defects (L6 sacralization), reduced chondrocyte migratory potential, and decreased expression of matrilin-3 and matrilin-4, indicating NAC1 participates in chondrocyte motility and differentiation.","method":"Knockout mouse model, skeletal phenotyping, chondrocyte migration assay, immunostaining, gene expression analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic KO with defined cellular and molecular phenotype","pmids":["23922682"],"is_preprint":false},{"year":2013,"finding":"NAC1 regulates FOXQ1 expression: NAC1 knockdown decreases FOXQ1 promoter activity and transcript; ectopic NAC1 induces FOXQ1; constitutive FOXQ1 expression rescues cell motility after NAC1 silencing, placing FOXQ1 downstream of NAC1 in cell movement regulation.","method":"siRNA knockdown, ectopic expression, luciferase reporter (promoter activity), rescue experiment, transcriptome profiling","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — gain/loss of function with promoter assay and epistatic rescue","pmids":["24200849"],"is_preprint":false},{"year":2014,"finding":"Crystal structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1 reveal the structural basis of POZ-domain heterodimer formation; Nac1 was identified as an interactor of Miz1 via POZ domain heterodimeric interaction, and Nac1 relocalizes Miz1 to NAC1 nuclear bodies; Nac1 siRNA knockdown increases p21Cip1 levels, consistent with relief of Miz1 inhibition.","method":"Chemical crosslinking, X-ray crystallography, co-immunoprecipitation, immunofluorescence, siRNA knockdown","journal":"Acta crystallographica Section F / Bioscience reports","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with functional validation by co-IP and siRNA knockdown","pmids":["25484205","24702277"],"is_preprint":false},{"year":2016,"finding":"Nac1 coordinates ES cell differentiation by activating Oct4 and inhibiting both Sox2 and Tcf3; Nac1, Oct4, Tcf3, and Sox2 form a sub-network governing mesendodermal vs. neuroectodermal fate choice.","method":"Integrative gene expression analysis, quantitative constraints modeling, gain/loss of function in mESCs","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — integrative approach with functional validation, single lab","pmids":["26832399"],"is_preprint":false},{"year":2017,"finding":"NAC1 promotes somatic cell reprogramming by facilitating NANOG binding to the E-cadherin promoter and by transcriptionally repressing ZEB1 (directly) and post-transcriptionally activating miR-200 miRNAs (indirectly) to upregulate E-cadherin expression.","method":"siRNA/shRNA knockdown, ChIP, promoter-reporter assay, miR-200 expression analysis, iPSC generation efficiency","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP, reporter assay, and functional reprogramming readout with epistatic analysis","pmids":["28781078"],"is_preprint":false},{"year":2017,"finding":"NAC1 overexpression drives drug resistance in colorectal cancer cells via induction of HOXA9 expression; knockdown of HOXA9 abrogates NAC1-induced resistance, establishing a NAC1→HOXA9 axis in chemoresistance.","method":"siRNA knockdown, ectopic overexpression, cell viability assay, caspase-3/7 activity","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 3 — epistasis demonstrated but single lab and limited mechanistic depth","pmids":["28713930"],"is_preprint":false},{"year":2017,"finding":"NAC1 mediates suppression of mitochondrial function in hypoxia through HIF-1α-induced expression of PDK3; NAC1-PDK3 axis inactivates pyruvate dehydrogenase and attenuates mitochondrial respiration, protecting cancer cells from apoptosis; re-expression of PDK3 in NAC1-absent cells rescues glycolysis.","method":"siRNA knockdown, ectopic expression, metabolic assays (glycolysis, oxygen consumption), xenograft model, qRT-PCR","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo rescue experiment with metabolic measurements","pmids":["29163184"],"is_preprint":false},{"year":2018,"finding":"NAC1 forms a protein complex with CARM1 (identified by LC-MS/MS) in ovarian cancer cells; the NAC1 complex has an apparent molecular mass of 300-500 kDa (much larger than the 58 kDa monomer), indicating higher-order complex formation.","method":"FPLC size-exclusion chromatography, LC-MS/MS, co-immunoprecipitation, tissue microarray","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — MS identification with Co-IP confirmation, single lab","pmids":["29983869"],"is_preprint":false},{"year":2019,"finding":"NAC1 bridges MAVS and TBK1 in the RLR antiviral signaling pathway: NAC1's BTB/POZ domain (aa 1-133) interacts with MAVS while the remaining portion binds TBK1; NAC1 promotes TBK1 recruitment to MAVS, enhancing TBK1 and IRF3 activation and IFN-β induction upon viral infection.","method":"Co-immunoprecipitation (overexpression and virus-induced), domain mapping, siRNA knockdown, overexpression with reporter assay, antiviral assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — domain mapping, functional Co-IP, reciprocal KD/OE with defined pathway placement","pmids":["31235549"],"is_preprint":false},{"year":2019,"finding":"Met7 and Leu90 in NAC1's N-terminal domain (aa 1-130) are critical for homodimerization and stability; small molecule NIC3 selectively binds Leu-90, prevents homodimerization, and leads to proteasomal NAC1 degradation, sensitizing drug-resistant tumor cells to chemotherapy.","method":"Computational analysis, high-throughput screening, in vitro binding assay, site-directed mutagenesis, cell viability assay, xenograft model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of dimerization interface combined with HTS and in vivo validation","pmids":["31101655"],"is_preprint":false},{"year":2019,"finding":"NAC1 interacts with Parkin and co-localizes with it in neurons; NAC1 overexpression promotes ubiquitin-dependent proteasomal degradation of Parkin, decreases proteasomal activity, and increases cellular susceptibility to proteasome inhibition-induced toxicity; POZ/BTB domain mutation Q23L disrupts NAC1-Parkin interaction.","method":"Co-immunoprecipitation, co-localization imaging, proteasome activity assay, mutagenesis, cell viability assay","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, mutagenesis, functional assay; single lab","pmids":["24231739"],"is_preprint":false},{"year":2020,"finding":"NAC1 interacts with BCL6 via its C-terminal BEN domain; the NAC1-BCL6 complex binds the FOXQ1 promoter and activates FOXQ1 transcription; NAC1 also attenuates BCL6 negative autoregulation in ovarian cancer cells.","method":"Cistrome database analysis, ChIP, co-immunoprecipitation, luciferase reporter assay, microarray analysis","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and Co-IP with functional reporter, single lab","pmids":["32412910"],"is_preprint":false},{"year":2022,"finding":"NAC1 is a negative regulator of FoxP3 in regulatory T cells (Tregs); NAC1−/− mice show increased CD4+ Tregs with higher FoxP3 acetylation and expression, slower FoxP3 turnover, and enhanced immune-suppressive activity; proinflammatory cytokines (IL-1β, TNF-α) induce NAC1 and decrease FoxP3.","method":"Knockout mouse model, flow cytometry, Treg functional assays, FoxP3 acetylation/stability measurements","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with defined molecular (FoxP3 acetylation) and cellular (Treg activity) readouts","pmids":["35767626"],"is_preprint":false},{"year":2022,"finding":"Tumorous expression of NAC1 positively regulates LDHA expression at the transcriptional level, increasing lactic acid accumulation in the tumor microenvironment, which inhibits cytokine production and induces exhaustion/apoptosis of CD8+ CTLs; NAC1-depleted tumors show elevated CTL infiltration.","method":"CRISPR/Cas9 NAC1 knockout, glycolysis analysis, retroviral transduction, flow cytometry, adoptive cell transfer in immunocompetent mice","journal":"Journal for immunotherapy of cancer","confidence":"High","confidence_rationale":"Tier 2 — CRISPR KO with in vivo adoptive transfer and defined molecular mechanism (LDHA/lactic acid)","pmids":["36150745"],"is_preprint":false},{"year":2022,"finding":"NAC1 is a multi-SUMO-site acceptor; SUMOylation at K167, K318, K368, K483, and K498 does not alter NAC1 localization but facilitates NAC1 nuclear body formation; SUMO-site mutant NAC1 suppresses cell proliferation and tumor growth compared to wild-type NAC1.","method":"SUMO site mutagenesis, SUMOylation assay, immunofluorescence, cell proliferation assay, animal tumor model","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — systematic mutagenesis with functional readout","pmids":["36527749"],"is_preprint":false},{"year":2023,"finding":"NAC1 nuclear export is mediated by a nuclear export signal (NES) at aa 17-28; docetaxel treatment triggers nuclear-cytoplasmic shuttling of NAC1; cytoplasmic NAC1 binds cullin3 (Cul3) via its BTB domain and Cyclin B1 via its BOZ domain, forming an E3 ubiquitin ligase complex that ubiquitinates and degrades Cyclin B1, facilitating mitotic exit and docetaxel resistance.","method":"NES mapping, domain-specific binding assays, ubiquitination assay, Cyclin B1 degradation assay, NES-blocking peptide in vitro and in vivo","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — domain mapping, ubiquitination assay, in vitro/in vivo validation with NES-blocking peptide","pmids":["37019189"],"is_preprint":false},{"year":2023,"finding":"NAC1 (Nacc1) R284W (human R298W) mutant impairs glutamatergic neurotransmission in a cell-autonomous, dominant-negative manner in autaptic mouse neurons; the mutant shows reduced binding to SynGAP1 and GluK2A, and greatly increased SUMOylation; ablating SUMOylation of Nacc1-R284W partially restores SynGAP1 binding. SynGAP1, GluK2A, and several SUMO E3 ligases were identified as novel Nacc1 interaction partners in the brain.","method":"Electrophysiology (autaptic neuron recordings), co-immunoprecipitation, SUMOylation assay, brain interactome screen","journal":"Frontiers in molecular neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiology with molecular mechanism (SUMOylation, binding partners) in disease-relevant mutant","pmids":["37533751"],"is_preprint":false},{"year":2024,"finding":"In the Nacc1-R284W knock-in mouse model, the mutation causes epileptiform discharges, behavioral seizures, and altered synaptic gene expression (upregulation of postsynapse and ion channel genes); NACC1 nuclear immunoreactivity increases in cortical pyramidal neurons and parvalbumin interneurons, and levels of synaptic proteins are changed.","method":"Knock-in mouse model, EEG, behavioral testing, RNA-seq, immunohistochemistry, synaptic protein analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — engineered knock-in mouse with EEG, RNA-seq, and protein-level validation","pmids":["38388424"],"is_preprint":false},{"year":2023,"finding":"NAC1 restrains CD4+ T-cell memory formation through the ROCK1-mediated autophagy pathway; NAC1-deficient CD4+ T cells have reduced ROCK1 expression, impaired BECLIN1 phosphorylation/stabilization, and defective autophagy; forced ROCK1 expression in NAC1−/− CD4+ T cells restores autophagy and abrogates enhanced memory formation.","method":"Knockout mouse model, adoptive transfer, viral infection model, ROCK1 overexpression rescue, AMPK-mTOR pathway analysis, autophagy flux assay","journal":"Journal of medical virology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with rescue experiment and defined pathway placement","pmids":["37465969"],"is_preprint":false},{"year":2025,"finding":"Treg-specific NAC1 deficiency upregulates FoxP3 expression and CD36-mediated lipid metabolism in Tregs, enhancing their metabolic fitness and immunosuppressive function in acidic tumor microenvironments; NAC1-deficient Tregs show enhanced tumoral infiltration and support tumor growth.","method":"Conditional Treg-specific NAC1 deletion, xenograft mouse models, adoptive Treg transfer, metabolic assays (lipid uptake, mitochondrial function)","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic metabolic studies with in vivo adoptive transfer; single lab","pmids":["39773913"],"is_preprint":false}],"current_model":"NACC1 encodes a BTB/POZ-domain transcriptional co-repressor that homodimerizes (via BTB/POZ) and forms large nuclear complexes to repress target genes (including Gadd45GIP1, FOXQ1, ZEB1, and LDHA) by recruiting HDAC3/4 and CoREST; it also heterodimerizes with other POZ proteins (BCL6, Miz1, ZID, ZF5) and interacts with CARM1 and the pluripotency factor Nanog; in neurons it associates with the proteasome and mediates its recruitment to dendritic spines via a PKC-S245 phosphorylation-regulated nuclear-cytoplasmic shuttling mechanism; in cancer cells it acts as an actin-binding protein required for cytokinesis, undergoes nuclear export via an N-terminal NES to form a Cul3 E3 ligase complex that degrades Cyclin B1 and promotes taxane resistance, and is multi-SUMOylated to stabilize nuclear bodies; in immune cells it suppresses FoxP3 stability in Tregs, restrains CD8+ and CD4+ T-cell memory formation (via ROCK1/autophagy and IRF4 pathways), and bridges MAVS-TBK1 to potentiate antiviral type I IFN signaling; a recurrent de novo p.Arg298Trp mutation causes a neurodevelopmental syndrome by impairing glutamatergic neurotransmission, reducing SynGAP1/GluK2A binding, and increasing pathological SUMOylation."},"narrative":{"teleology":[{"year":1997,"claim":"Identifying NACC1 as a cocaine-regulated POZ/BTB-domain gene in the nucleus accumbens established its neural expression and domain architecture, opening the question of its molecular function.","evidence":"cDNA cloning with in situ hybridization and Northern blot in rat brain after cocaine self-administration","pmids":["9278521"],"confidence":"High","gaps":["No function assigned beyond expression pattern","POZ domain role uncharacterized"]},{"year":2000,"claim":"Demonstrating that NAC1 represses transcription via its POZ domain and that overexpression blocks cocaine sensitization established it as a nuclear transcriptional repressor with behavioral relevance.","evidence":"Gal4-luciferase reporter assay, mammalian two-hybrid, adenoviral overexpression in rat nucleus accumbens","pmids":["10934270"],"confidence":"High","gaps":["Corepressor recruitment mechanism unknown","Direct DNA-binding capacity unresolved"]},{"year":2005,"claim":"Identification of HDAC3/4 and CoREST as direct NAC1 partners, and PKC-S245 phosphorylation as a switch for nuclear-cytoplasmic distribution, defined the enzymatic basis of NAC1-mediated repression and its activity-dependent regulation in neurons.","evidence":"Co-IP, GST pulldown, HDAC inhibitor rescue of reporter repression; PKC-site mutagenesis with immunofluorescence in primary neurons","pmids":["16033423","16045493","17254023"],"confidence":"High","gaps":["Direct genomic targets of NAC1 repression not yet mapped","Whether HDAC3 vs. HDAC4 recruitment is context-specific"]},{"year":2007,"claim":"Discovery that NAC1 recruits the proteasome to dendritic spines in an activity-dependent manner, and that it represses Gadd45GIP1 to sustain cancer cell growth, revealed dual cytoplasmic and nuclear effector functions.","evidence":"Co-IP of NAC1 with proteasome subunits, Nac1 KO neurons lacking spine proteasome recruitment; SAGE-based target identification with siRNA/ectopic expression in cancer cells","pmids":["17699672","17804717"],"confidence":"High","gaps":["Mechanism of proteasome cargo recognition by NAC1 unclear","Whether Gadd45GIP1 is a direct transcriptional target not resolved by ChIP"]},{"year":2009,"claim":"Crystal structure of the NAC1 POZ domain at 2.1 Å confirmed dimeric architecture, while functional studies showed homodimerization is essential for paclitaxel resistance via the Gadd45 pathway and that NAC1 interacts with Nanog to regulate ES cell proliferation.","evidence":"X-ray crystallography; dominant-negative disruption of homodimerization with chemosensitivity assays; Nanog-NAC1 co-IP with ERas/PI3K pathway readouts","pmids":["19407373","19305429","19366700"],"confidence":"High","gaps":["How NAC1 transitions between transcription factor and ES cell pluripotency roles","No co-crystal with DNA or HDAC partners"]},{"year":2012,"claim":"Identification of NAC1 as an actin monomer-binding protein required for cytokinesis, and mapping of its bipartite NLS, revealed a structural role in cell division beyond transcriptional repression.","evidence":"Direct actin-binding assay, multinucleation phenotype upon NAC1 loss, rescue in Nac1-null fibroblasts; NLS mutagenesis with importin pathway inhibition","pmids":["22761335","22665369"],"confidence":"High","gaps":["Whether actin binding and transcriptional repression are separable functions in vivo","Structural basis of actin-BTB domain interaction unknown"]},{"year":2014,"claim":"Crystal structures of NAC1-Miz1 and BCL6-Miz1 POZ heterodimers defined the structural basis for NAC1 heterodimerization and showed that NAC1 sequesters Miz1 into nuclear bodies to relieve p21 repression.","evidence":"X-ray crystallography of heterodimeric POZ complexes, co-IP, siRNA knockdown of NAC1 increasing p21","pmids":["25484205","24702277"],"confidence":"High","gaps":["Full repertoire of POZ heterodimer partners in vivo not defined","Genome-wide transcriptional consequences of Miz1 sequestration unknown"]},{"year":2019,"claim":"NAC1 was shown to bridge MAVS and TBK1 via distinct domains to potentiate type I IFN signaling, establishing an innate immune function; separately, critical dimerization residues (Met7, Leu90) were mapped and targeted by the small molecule NIC3.","evidence":"Domain-mapping co-IP with viral infection; HTS identifying NIC3, mutagenesis of Leu90, xenograft chemosensitization","pmids":["31235549","31101655"],"confidence":"High","gaps":["Whether NAC1's antiviral role operates in vivo during natural infection","Pharmacokinetics and selectivity of NIC3 in vivo"]},{"year":2022,"claim":"Genetic studies in Nacc1−/− mice revealed NAC1 as a negative regulator of FoxP3 stability in Tregs and of LDHA-driven lactic acid production in tumors, linking NAC1 to adaptive immune regulation and tumor immune evasion.","evidence":"Knockout mouse with FoxP3 acetylation/stability assays; CRISPR KO with adoptive T-cell transfer in immunocompetent mice","pmids":["35767626","36150745"],"confidence":"High","gaps":["Direct mechanism by which NAC1 promotes FoxP3 deacetylation not identified","Whether LDHA is a direct transcriptional target confirmed by ChIP"]},{"year":2022,"claim":"Systematic SUMO-site mutagenesis showed that multi-site SUMOylation facilitates NAC1 nuclear body formation and is required for its pro-proliferative activity, adding a post-translational layer to nuclear body regulation.","evidence":"Mutagenesis of five SUMO sites, SUMOylation assay, nuclear body imaging, tumor growth assay","pmids":["36527749"],"confidence":"Medium","gaps":["Identity of SUMO E3 ligases acting on NAC1 in cancer cells not defined","Whether SUMOylation modulates specific transcriptional targets"]},{"year":2023,"claim":"Mapping of an N-terminal NES and demonstration that cytoplasmic NAC1 forms a Cul3 E3 ligase targeting Cyclin B1 for degradation explained how NAC1 promotes mitotic exit and taxane resistance, unifying its nuclear export and ubiquitin ligase activities.","evidence":"NES mapping, ubiquitination assay, Cyclin B1 degradation kinetics, NES-blocking peptide in xenograft","pmids":["37019189"],"confidence":"High","gaps":["Whether Cyclin B1 is the sole Cul3-NAC1 substrate","How NES-mediated export is triggered specifically by taxanes"]},{"year":2023,"claim":"The recurrent R298W mutation was shown to impair glutamatergic neurotransmission cell-autonomously by reducing SynGAP1/GluK2A binding and increasing pathological SUMOylation, providing a molecular mechanism for the associated neurodevelopmental syndrome.","evidence":"Autaptic neuron electrophysiology, co-IP of mutant vs. wild-type interactomes, SUMOylation assays with rescue","pmids":["37533751"],"confidence":"High","gaps":["Whether SUMOylation-ablated R298W fully rescues synaptic function in vivo","Which SUMO E3 ligase(s) preferentially modify the mutant"]},{"year":2024,"claim":"A Nacc1-R284W knock-in mouse recapitulated epilepsy with altered synaptic gene networks, validating the mutation as causal for the human neurodevelopmental phenotype and revealing compensatory transcriptional changes.","evidence":"Knock-in mouse with EEG, behavioral seizure scoring, RNA-seq, immunohistochemistry","pmids":["38388424"],"confidence":"High","gaps":["Whether seizures arise from excitatory neuron, interneuron, or circuit-level dysfunction","Therapeutic targets within the dysregulated synaptic gene network not identified"]},{"year":null,"claim":"Key unresolved questions include the genome-wide direct target repertoire of NAC1 (by ChIP-seq), the structural basis of NAC1's interactions with non-POZ partners (HDAC3/4, proteasome, SynGAP1), how SUMOylation versus phosphorylation coordinately regulate NAC1 function in different cell types, and the full substrate spectrum of the Cul3-NAC1 E3 ligase.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide ChIP-seq for direct NAC1 binding sites published","No structure of NAC1 in complex with HDAC, proteasome, or synaptic partners","Interplay between SUMOylation and S245 phosphorylation not studied"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,4,7,9,19,22]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[16]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[26,33]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,6,15,17]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,33]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[15]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,4,7,9,19,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[26,30,31,36,37]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[15,16,33]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[14,36]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[33,28]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,11]}],"complexes":["CoREST complex","Cul3 E3 ubiquitin ligase complex"],"partners":["HDAC3","HDAC4","RCOR1","BCL6","ZBTB17","CUL3","MAVS","TBK1"],"other_free_text":[]},"mechanistic_narrative":"NACC1 is a BTB/POZ-domain transcriptional co-repressor that homodimerizes to form dynamic nuclear bodies and recruits chromatin-modifying complexes—including HDAC3/4 and CoREST—to repress target genes such as Gadd45GIP1, FOXQ1, and ZEB1, while also heterodimerizing with other BTB/POZ proteins (BCL6, Miz1, ZID, ZF5) to modulate their transcriptional activities [PMID:10934270, PMID:16033423, PMID:17254023, PMID:25484205]. In neurons, NACC1 mediates activity-dependent recruitment of the proteasome to dendritic spines through PKC-dependent phosphorylation at S245 that governs its nuclear–cytoplasmic shuttling, and interacts with synaptic proteins SynGAP1 and GluK2A to support glutamatergic neurotransmission; a recurrent de novo R298W mutation causes a neurodevelopmental syndrome with epilepsy by disrupting these synaptic interactions and pathologically increasing SUMOylation [PMID:17699672, PMID:16045493, PMID:37533751, PMID:38388424]. In the immune system, NACC1 destabilizes FoxP3 in regulatory T cells, restrains CD4+ and CD8+ T-cell memory formation via ROCK1/autophagy signaling, and bridges MAVS to TBK1 to potentiate type I interferon responses during viral infection [PMID:35767626, PMID:37465969, PMID:31235549]. In cancer cells, cytoplasmic NACC1 assembles a Cul3-based E3 ubiquitin ligase that degrades Cyclin B1 to promote mitotic exit and taxane resistance, and its multi-site SUMOylation stabilizes nuclear bodies required for proliferation [PMID:37019189, PMID:36527749]."},"prefetch_data":{"uniprot":{"accession":"Q96RE7","full_name":"Nucleus accumbens-associated protein 1","aliases":["BTB/POZ domain-containing protein 14B"],"length_aa":527,"mass_kda":57.3,"function":"Functions as a transcriptional repressor. Seems to function as a transcriptional corepressor in neuronal cells through recruitment of HDAC3 and HDAC4. Contributes to tumor progression, and tumor cell proliferation and survival. This may be mediated at least in part through repressing transcriptional activity of GADD45GIP1. Required for recruiting the proteasome from the nucleus to the cytoplasm and dendritic spines","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q96RE7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NACC1","classification":"Not Classified","n_dependent_lines":60,"n_total_lines":1208,"dependency_fraction":0.04966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NACC1","total_profiled":1310},"omim":[{"mim_id":"617393","title":"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM","url":"https://www.omim.org/entry/617393"},{"mim_id":"616770","title":"MICRO RNA 218-1; MIR218-1","url":"https://www.omim.org/entry/616770"},{"mim_id":"610672","title":"NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC1","url":"https://www.omim.org/entry/610672"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NACC1"},"hgnc":{"alias_symbol":["NAC1","NAC-1","BEND8","BTBD30"],"prev_symbol":["BTBD14B"]},"alphafold":{"accession":"Q96RE7","domains":[{"cath_id":"3.30.710.10","chopping":"14-123","consensus_level":"medium","plddt":91.9626,"start":14,"end":123},{"cath_id":"1.10.10.2590","chopping":"340-421_428-475","consensus_level":"medium","plddt":85.5018,"start":340,"end":475}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96RE7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96RE7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96RE7-F1-predicted_aligned_error_v6.png","plddt_mean":63.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NACC1","jax_strain_url":"https://www.jax.org/strain/search?query=NACC1"},"sequence":{"accession":"Q96RE7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96RE7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96RE7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96RE7"}},"corpus_meta":[{"pmid":"15829603","id":"PMC_15829603","title":"MicroRNA directs mRNA cleavage of the transcription factor NAC1 to downregulate auxin signals for arabidopsis lateral root development.","date":"2005","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/15829603","citation_count":663,"is_preprint":false},{"pmid":"11114891","id":"PMC_11114891","title":"Arabidopsis NAC1 transduces auxin signal downstream of TIR1 to promote lateral root development.","date":"2000","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11114891","citation_count":639,"is_preprint":false},{"pmid":"12226665","id":"PMC_12226665","title":"SINAT5 promotes ubiquitin-related degradation of NAC1 to attenuate auxin signals.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12226665","citation_count":369,"is_preprint":false},{"pmid":"17130457","id":"PMC_17130457","title":"A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17130457","citation_count":118,"is_preprint":false},{"pmid":"21743489","id":"PMC_21743489","title":"NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21743489","citation_count":108,"is_preprint":false},{"pmid":"25318938","id":"PMC_25318938","title":"A STRESS-RESPONSIVE NAC1-regulated protein phosphatase gene rice protein phosphatase18 modulates drought and oxidative stress tolerance through abscisic acid-independent reactive oxygen species scavenging in rice.","date":"2014","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25318938","citation_count":103,"is_preprint":false},{"pmid":"21337010","id":"PMC_21337010","title":"A structural view of the conserved domain of rice stress-responsive NAC1.","date":"2011","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/21337010","citation_count":78,"is_preprint":false},{"pmid":"19305429","id":"PMC_19305429","title":"NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19305429","citation_count":72,"is_preprint":false},{"pmid":"9278521","id":"PMC_9278521","title":"NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9278521","citation_count":72,"is_preprint":false},{"pmid":"30442370","id":"PMC_30442370","title":"LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30442370","citation_count":69,"is_preprint":false},{"pmid":"24043850","id":"PMC_24043850","title":"Grapevine NAC1 transcription factor as a convergent node in developmental processes, abiotic stresses, and necrotrophic/biotrophic pathogen tolerance.","date":"2013","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/24043850","citation_count":68,"is_preprint":false},{"pmid":"10934270","id":"PMC_10934270","title":"NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10934270","citation_count":64,"is_preprint":false},{"pmid":"17804717","id":"PMC_17804717","title":"NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17804717","citation_count":64,"is_preprint":false},{"pmid":"20508725","id":"PMC_20508725","title":"Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas.","date":"2010","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20508725","citation_count":59,"is_preprint":false},{"pmid":"34416910","id":"PMC_34416910","title":"FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34416910","citation_count":57,"is_preprint":false},{"pmid":"17699672","id":"PMC_17699672","title":"NAC1 regulates the recruitment of the proteasome complex into dendritic spines.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17699672","citation_count":54,"is_preprint":false},{"pmid":"21240255","id":"PMC_21240255","title":"Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.","date":"2011","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/21240255","citation_count":52,"is_preprint":false},{"pmid":"18483383","id":"PMC_18483383","title":"A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18483383","citation_count":43,"is_preprint":false},{"pmid":"21770944","id":"PMC_21770944","title":"Transcriptional and post-transcriptional regulation of a NAC1 transcription factor in Medicago truncatula roots.","date":"2011","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/21770944","citation_count":42,"is_preprint":false},{"pmid":"16033423","id":"PMC_16033423","title":"The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16033423","citation_count":41,"is_preprint":false},{"pmid":"28132692","id":"PMC_28132692","title":"A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28132692","citation_count":39,"is_preprint":false},{"pmid":"26553360","id":"PMC_26553360","title":"miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26553360","citation_count":39,"is_preprint":false},{"pmid":"17254023","id":"PMC_17254023","title":"NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17254023","citation_count":37,"is_preprint":false},{"pmid":"22761335","id":"PMC_22761335","title":"NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22761335","citation_count":37,"is_preprint":false},{"pmid":"6034504","id":"PMC_6034504","title":"The formation and continuous turnover of a fraction of phosphatidic acid on stimulation of NaC1 secretion by acetylcholine in the salt gland.","date":"1967","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/6034504","citation_count":37,"is_preprint":false},{"pmid":"21889186","id":"PMC_21889186","title":"Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.","date":"2011","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21889186","citation_count":37,"is_preprint":false},{"pmid":"25040333","id":"PMC_25040333","title":"Contribution of the drought tolerance-related stress-responsive NAC1 transcription factor to resistance of barley to Ramularia leaf spot.","date":"2014","source":"Molecular plant pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25040333","citation_count":36,"is_preprint":false},{"pmid":"36809880","id":"PMC_36809880","title":"NAC1 regulates root ground tissue maturation by coordinating with the SCR/SHR-CYCD6;1 module in Arabidopsis.","date":"2023","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/36809880","citation_count":34,"is_preprint":false},{"pmid":"33999553","id":"PMC_33999553","title":"A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.","date":"2021","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33999553","citation_count":34,"is_preprint":false},{"pmid":"22653145","id":"PMC_22653145","title":"Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas.","date":"2012","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22653145","citation_count":32,"is_preprint":false},{"pmid":"36107155","id":"PMC_36107155","title":"Cowpea NAC1/NAC2 transcription factors improve growth and tolerance to drought and heat in transgenic cowpea through combined activation of photosynthetic and antioxidant mechanisms.","date":"2022","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/36107155","citation_count":32,"is_preprint":false},{"pmid":"19121354","id":"PMC_19121354","title":"NAC1, a POZ/BTB protein that functions as a corepressor.","date":"2008","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/19121354","citation_count":31,"is_preprint":false},{"pmid":"26832399","id":"PMC_26832399","title":"Nac1 Coordinates a Sub-network of Pluripotency Factors to Regulate Embryonic Stem Cell Differentiation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26832399","citation_count":30,"is_preprint":false},{"pmid":"10400893","id":"PMC_10400893","title":"Interrupted expression of NAC-1 augments the behavioral responses to cocaine.","date":"1999","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10400893","citation_count":29,"is_preprint":false},{"pmid":"17391728","id":"PMC_17391728","title":"Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions.","date":"2007","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17391728","citation_count":27,"is_preprint":false},{"pmid":"24200849","id":"PMC_24200849","title":"Identification of the NAC1-regulated genes in ovarian cancer.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24200849","citation_count":26,"is_preprint":false},{"pmid":"36150745","id":"PMC_36150745","title":"Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion.","date":"2022","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36150745","citation_count":26,"is_preprint":false},{"pmid":"20372782","id":"PMC_20372782","title":"NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma.","date":"2010","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20372782","citation_count":25,"is_preprint":false},{"pmid":"21301057","id":"PMC_21301057","title":"Cell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology.","date":"2011","source":"Physical biology","url":"https://pubmed.ncbi.nlm.nih.gov/21301057","citation_count":24,"is_preprint":false},{"pmid":"25484205","id":"PMC_25484205","title":"Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.","date":"2014","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/25484205","citation_count":24,"is_preprint":false},{"pmid":"32735888","id":"PMC_32735888","title":"Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32735888","citation_count":23,"is_preprint":false},{"pmid":"29983869","id":"PMC_29983869","title":"Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29983869","citation_count":22,"is_preprint":false},{"pmid":"30248959","id":"PMC_30248959","title":"NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30248959","citation_count":22,"is_preprint":false},{"pmid":"19366700","id":"PMC_19366700","title":"The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19366700","citation_count":22,"is_preprint":false},{"pmid":"19188150","id":"PMC_19188150","title":"Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen.","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19188150","citation_count":22,"is_preprint":false},{"pmid":"37813193","id":"PMC_37813193","title":"Molecular mechanisms of SNAC1 (Stress-responsive NAC1) in conferring the abiotic stress tolerance.","date":"2023","source":"Plant science : an international journal of experimental plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/37813193","citation_count":21,"is_preprint":false},{"pmid":"28713930","id":"PMC_28713930","title":"Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28713930","citation_count":21,"is_preprint":false},{"pmid":"11906783","id":"PMC_11906783","title":"Differences in expression, actions and cocaine regulation of two isoforms for the brain transcriptional regulator NAC1.","date":"2002","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11906783","citation_count":21,"is_preprint":false},{"pmid":"35767626","id":"PMC_35767626","title":"NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35767626","citation_count":20,"is_preprint":false},{"pmid":"31101655","id":"PMC_31101655","title":"Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31101655","citation_count":20,"is_preprint":false},{"pmid":"29163184","id":"PMC_29163184","title":"Silencing of NAC1 Expression Induces Cancer Cells Oxidative Stress in Hypoxia and Potentiates the Therapeutic Activity of Elesclomol.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29163184","citation_count":20,"is_preprint":false},{"pmid":"27544199","id":"PMC_27544199","title":"Function of Hevea brasiliensis NAC1 in dehydration-induced laticifer differentiation and latex biosynthesis.","date":"2016","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/27544199","citation_count":20,"is_preprint":false},{"pmid":"29864683","id":"PMC_29864683","title":"Targeting oncogenic transcriptional corepressor Nac1 POZ domain with conformationally constrained peptides by cyclization and stapling.","date":"2018","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29864683","citation_count":20,"is_preprint":false},{"pmid":"23922682","id":"PMC_23922682","title":"Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23922682","citation_count":19,"is_preprint":false},{"pmid":"31490008","id":"PMC_31490008","title":"CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31490008","citation_count":19,"is_preprint":false},{"pmid":"19407373","id":"PMC_19407373","title":"Structure of the human Nac1 POZ domain.","date":"2009","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/19407373","citation_count":19,"is_preprint":false},{"pmid":"32821163","id":"PMC_32821163","title":"MiR-218-5p Suppresses the Progression of Retinoblastoma Through Targeting NACC1 and Inhibiting the AKT/mTOR Signaling Pathway.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32821163","citation_count":18,"is_preprint":false},{"pmid":"33174734","id":"PMC_33174734","title":"Systemic Delivery of NAC-1 siRNA by Neuropilin-Targeted Polymersomes Sensitizes Antiangiogenic Therapy of Metastatic Triple-Negative Breast Cancer.","date":"2020","source":"Biomacromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33174734","citation_count":18,"is_preprint":false},{"pmid":"22665369","id":"PMC_22665369","title":"Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22665369","citation_count":16,"is_preprint":false},{"pmid":"22024751","id":"PMC_22024751","title":"NAC1 and HMGB1 enter a partnership for manipulating autophagy.","date":"2011","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/22024751","citation_count":16,"is_preprint":false},{"pmid":"31235549","id":"PMC_31235549","title":"NAC1 Potentiates Cellular Antiviral Signaling by Bridging MAVS and TBK1.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31235549","citation_count":15,"is_preprint":false},{"pmid":"24702277","id":"PMC_24702277","title":"Nac1 interacts with the POZ-domain transcription factor, Miz1.","date":"2014","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/24702277","citation_count":15,"is_preprint":false},{"pmid":"14521994","id":"PMC_14521994","title":"The mouse nac1 gene, encoding a cocaine-regulated Bric-a-brac Tramtrac Broad complex/Pox virus and Zinc finger protein, is regulated by AP1.","date":"2003","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14521994","citation_count":15,"is_preprint":false},{"pmid":"34419960","id":"PMC_34419960","title":"Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.","date":"2022","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/34419960","citation_count":14,"is_preprint":false},{"pmid":"28781078","id":"PMC_28781078","title":"NAC1 Regulates Somatic Cell Reprogramming by Controlling Zeb1 and E-cadherin Expression.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28781078","citation_count":14,"is_preprint":false},{"pmid":"16045493","id":"PMC_16045493","title":"Activity-dependent subcellular localization of NAC1.","date":"2005","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16045493","citation_count":13,"is_preprint":false},{"pmid":"36293114","id":"PMC_36293114","title":"NAC1 Maintains Root Meristem Activity by Repressing the Transcription of E2Fa in Arabidopsis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36293114","citation_count":13,"is_preprint":false},{"pmid":"32091103","id":"PMC_32091103","title":"NACC-1 regulates hepatocellular carcinoma cell malignancy and is targeted by miR-760.","date":"2020","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/32091103","citation_count":12,"is_preprint":false},{"pmid":"35067807","id":"PMC_35067807","title":"MiR-361-3p alleviates cerebral ischemia-reperfusion injury by targeting NACC1 through the PINK1/Parkin pathway.","date":"2022","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/35067807","citation_count":12,"is_preprint":false},{"pmid":"36016335","id":"PMC_36016335","title":"Expression of NAC1 Restrains the Memory Formation of CD8+ T Cells during Viral Infection.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/36016335","citation_count":12,"is_preprint":false},{"pmid":"34691255","id":"PMC_34691255","title":"Silencing of NACC1 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via regulating the AKT/mTOR signaling pathway.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34691255","citation_count":11,"is_preprint":false},{"pmid":"32412910","id":"PMC_32412910","title":"NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32412910","citation_count":11,"is_preprint":false},{"pmid":"33859361","id":"PMC_33859361","title":"Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.","date":"2021","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/33859361","citation_count":11,"is_preprint":false},{"pmid":"10789989","id":"PMC_10789989","title":"Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma.","date":"1999","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/10789989","citation_count":11,"is_preprint":false},{"pmid":"38030057","id":"PMC_38030057","title":"An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects.","date":"2023","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38030057","citation_count":10,"is_preprint":false},{"pmid":"27424155","id":"PMC_27424155","title":"Protein complex formation and intranuclear dynamics of NAC1 in cancer cells.","date":"2016","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/27424155","citation_count":10,"is_preprint":false},{"pmid":"39590921","id":"PMC_39590921","title":"LncRNA81246 regulates resistance against tea leaf spot by interrupting the miR164d-mediated degradation of NAC1.","date":"2024","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39590921","citation_count":10,"is_preprint":false},{"pmid":"17945361","id":"PMC_17945361","title":"Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response.","date":"2007","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17945361","citation_count":10,"is_preprint":false},{"pmid":"37533751","id":"PMC_37533751","title":"An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission.","date":"2023","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37533751","citation_count":9,"is_preprint":false},{"pmid":"24231739","id":"PMC_24231739","title":"NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24231739","citation_count":9,"is_preprint":false},{"pmid":"29435019","id":"PMC_29435019","title":"NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFNβ.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29435019","citation_count":9,"is_preprint":false},{"pmid":"12759112","id":"PMC_12759112","title":"The relationship between cocaine-induced increases in NAC1 and behavioral sensitization.","date":"2003","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/12759112","citation_count":9,"is_preprint":false},{"pmid":"37577235","id":"PMC_37577235","title":"Exosome-transported circHDAC1_004 Promotes Proliferation, Migration, and Angiogenesis of Hepatocellular Carcinoma by the miR-361-3p/NACC1 Axis.","date":"2023","source":"Journal of clinical and translational hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/37577235","citation_count":8,"is_preprint":false},{"pmid":"17172049","id":"PMC_17172049","title":"Expression of NAC1 up-stream regulatory region and its relationship to the lateral root initiation induced by gibberellins and auxins.","date":"2006","source":"Science in China. Series C, Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17172049","citation_count":8,"is_preprint":false},{"pmid":"37465969","id":"PMC_37465969","title":"NAC1 confines virus-specific memory formation of CD4+ T cells through the ROCK1-mediated pathway.","date":"2023","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/37465969","citation_count":7,"is_preprint":false},{"pmid":"37189841","id":"PMC_37189841","title":"Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37189841","citation_count":7,"is_preprint":false},{"pmid":"12725910","id":"PMC_12725910","title":"NAC1, a POZ/BTB protein present in the adult mammalian brain, triggers apoptosis after adenovirus-mediated overexpression in PC-12 cells.","date":"2003","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12725910","citation_count":7,"is_preprint":false},{"pmid":"37019189","id":"PMC_37019189","title":"Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37019189","citation_count":6,"is_preprint":false},{"pmid":"34869110","id":"PMC_34869110","title":"A New Case of de novo Variant c.892C>T (p.Arg298Trp) in NACC1: A First Case Report From China.","date":"2021","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34869110","citation_count":6,"is_preprint":false},{"pmid":"39243032","id":"PMC_39243032","title":"NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer.","date":"2024","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39243032","citation_count":5,"is_preprint":false},{"pmid":"38388424","id":"PMC_38388424","title":"Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction.","date":"2024","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38388424","citation_count":5,"is_preprint":false},{"pmid":"36169794","id":"PMC_36169794","title":"A Low Grade Nasopharyngeal sarcoma With FUS::NACC1 Fusion and Immunohistochemical Evidence of Epithelial Differentiation: Expanding the Clinicopathologic Spectrum of an Emerging Entity.","date":"2022","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36169794","citation_count":5,"is_preprint":false},{"pmid":"30373858","id":"PMC_30373858","title":"NAC1/HMGB1 Signaling Pathway Is Associated with Epithelial-mesenchymal Transition, Invasion, and Metastasis of Lung Cancer Cell Line.","date":"2018","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/30373858","citation_count":5,"is_preprint":false},{"pmid":"26907779","id":"PMC_26907779","title":"[Expression analysis of miR164 and its target gene NAC1 in response to low nitrate availability in Betula luminifera].","date":"2016","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/26907779","citation_count":5,"is_preprint":false},{"pmid":"31412978","id":"PMC_31412978","title":"Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31412978","citation_count":4,"is_preprint":false},{"pmid":"22993327","id":"PMC_22993327","title":"NAC1, a BTB/POZ protein overexpressed in uterine sarcomas.","date":"2012","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22993327","citation_count":4,"is_preprint":false},{"pmid":"39773913","id":"PMC_39773913","title":"Metabolic fitness of NAC1-deficient Tregs in the tumor microenvironment fuels tumor growth.","date":"2025","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/39773913","citation_count":3,"is_preprint":false},{"pmid":"36527749","id":"PMC_36527749","title":"Multi-SUMOylation of NAC1 is essential for the growth of prostate cancer cells.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36527749","citation_count":3,"is_preprint":false},{"pmid":"37801618","id":"PMC_37801618","title":"Transcription factor NAC1 activates expression of peptidase-encoding AtCEPs in roots to limit root hair growth.","date":"2023","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37801618","citation_count":3,"is_preprint":false},{"pmid":"38698576","id":"PMC_38698576","title":"Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant.","date":"2024","source":"Movement disorders clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/38698576","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49556,"output_tokens":8717,"usd":0.139711},"stage2":{"model":"claude-opus-4-6","input_tokens":12596,"output_tokens":3704,"usd":0.23337},"total_usd":0.373081,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"NAC1 (NACC1) was identified as a novel transcript in rat nucleus accumbens encoding a protein with a POZ/BTB domain in its first 120 amino acids, and its mRNA levels were increased ~50% in nucleus accumbens 3 weeks after cocaine self-administration, establishing it as a cocaine-regulated gene in the brain.\",\n      \"method\": \"In situ transcription-PCR, in situ hybridization, Northern blot, cDNA cloning\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original discovery paper with multiple methods; independently replicated in subsequent studies\",\n      \"pmids\": [\"9278521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NAC1 acts as a transcriptional repressor localized to the nucleus of neurons; it represses reporter gene transcription and interacts with other POZ/BTB proteins via its POZ/BTB domain in mammalian two-hybrid studies; adenoviral overexpression of NAC1 in rat nucleus accumbens prevented development (but not expression) of cocaine-induced behavioral sensitization.\",\n      \"method\": \"Nuclear localization imaging, Gal4-luciferase reporter assay, mammalian two-hybrid, adenoviral overexpression in vivo\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter assay, two-hybrid, in vivo functional test); foundational paper\",\n      \"pmids\": [\"10934270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Two NAC1 isoforms (sNAC1 and lNAC1, differing by 27 amino acids) both repress transcription in HEK293T cells, but the shorter isoform represses less effectively; both show subnuclear punctate localization; cocaine transiently increases sNAC1 levels in the nucleus accumbens 2 h after acute injection.\",\n      \"method\": \"cDNA cloning, Western blot, Gal4-luciferase reporter assay, immunofluorescence, semi-quantitative RT-PCR\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in a single study\",\n      \"pmids\": [\"11906783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The mouse Nac1 gene contains a functional AP1 binding site in an intron 1 enhancer; co-transfection with c-jun/c-fos activated the wild-type enhancer, and mutation of the AP1 site abrogated activation, establishing AP1 as a transcriptional regulator of Nac1.\",\n      \"method\": \"Promoter-reporter (luciferase), site-directed mutagenesis, co-transfection\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis and reporter assay confirm AP1 regulation\",\n      \"pmids\": [\"14521994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NAC1 interacts with HDAC3 and HDAC4 via both its POZ domain and non-POZ regions; HDAC inhibition reverses NAC1-mediated transcriptional repression in neuronal-like cultures; NAC1 does not interact with NCoR, SMRT, or mSin3a, indicating selectivity for HDAC3/4 as corepressors.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, mammalian two-hybrid, Gal4-luciferase reporter assay\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal Co-IP, GST pulldown, and functional reporter assay with HDAC inhibitor validation\",\n      \"pmids\": [\"16033423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NAC1 subcellular localization is activity-dependent: phosphorylation of residue S245 by PKC is necessary for diffuse cytoplasmic localization outside the nucleus in differentiated neurons; tetrodotoxin blocks and high-K+ depolarization induces this diffuse distribution.\",\n      \"method\": \"PKC inhibitors/activators, systematic PKC-site mutagenesis, immunofluorescence in primary cortical neurons and differentiated PC12/Neuro2A cells\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of specific phosphorylation site combined with pharmacological evidence\",\n      \"pmids\": [\"16045493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NAC1 forms discrete nuclear bodies via homodimerization through the BTB/POZ domain; expression of a BTB/POZ-only dominant-negative disrupts these nuclear bodies, prevents tumor formation, and promotes apoptosis in cancer xenografts.\",\n      \"method\": \"Co-immunoprecipitation, double immunofluorescence, mouse xenograft model with dominant-negative expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, imaging, and in vivo functional validation with dominant-negative; replicated in subsequent studies\",\n      \"pmids\": [\"17130457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NAC1 negatively regulates transcription of Gadd45GIP1; NAC1 knockdown in SKOV3 and HeLa cells induces Gadd45GIP1 expression, while engineered NAC1 expression suppresses it; Gadd45GIP1 induction partially mediates NAC1 knockdown-induced growth arrest.\",\n      \"method\": \"SAGE, siRNA knockdown, ectopic NAC1 expression, luciferase reporter, in vitro and in vivo growth assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (gain/loss of function, SAGE, in vivo) in a single paper\",\n      \"pmids\": [\"17804717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NAC1 complexes with proteins in the ubiquitin-proteasome system (cullins, Mov34) and co-translocates with the proteasome from the nucleus into dendritic spines in cortical neurons in response to proteasome inhibition or disinhibiting synaptic activity (bicuculline); NAC1-deficient neurons fail to recruit the proteasome into dendritic spines and postsynaptic density.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, subcellular fractionation, Nac1 knockout neurons, dominant-negative NAC1 lacking proteasome-binding domain\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, imaging, genetic KO, and dominant-negative all converge on same mechanism\",\n      \"pmids\": [\"17699672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NAC1 interacts with CoREST via its POZ/BTB domain; this interaction is detected by co-immunoprecipitation in neuro-2A, HEK293T cells, and rat brain lysates; POZ/BTB homodimerization is not required for NAC1-CoREST interaction; siRNA-mediated NAC1 knockdown reverses CoREST-mediated transcriptional repression.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, siRNA knockdown, luciferase reporter assay, endogenous brain protein interaction\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, GST pulldown, functional reporter, and endogenous brain validation\",\n      \"pmids\": [\"17254023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NAC1 functions as a corepressor for multiple other POZ/BTB proteins (ZID, BCL6, ZF5, MAYVEN, NRP/B, BCoR) via its POZ/BTB domain; NAC1 does not interact with PLZF; endogenous NAC1 and BCL6 are physically associated in CNS regions.\",\n      \"method\": \"Mammalian two-hybrid, GST pulldown, co-immunoprecipitation from brain lysates, Gal4-reporter assay\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple protein-protein interaction methods with endogenous validation\",\n      \"pmids\": [\"19121354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NAC1 homodimerization contributes to paclitaxel resistance in ovarian cancer by negatively regulating the Gadd45 pathway; disruption of NAC1 homodimerization by dominant-negative BTB/POZ domain or siRNA knockdown induces Gadd45γ, which interacts with Gadd45gip1 to increase paclitaxel sensitivity.\",\n      \"method\": \"siRNA knockdown, dominant-negative expression, ectopic expression, cell viability assays, ex vivo tissue correlation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain and loss of function with defined downstream pathway; replicated across cell lines and tissue\",\n      \"pmids\": [\"19305429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The C-terminal pentapeptide WNAAP of Nanog's tryptophan repeat domain is sufficient for binding Nac1; Nanog and Nac1 synergistically upregulate ERas expression and promote ES cell proliferation via the PI3K/Akt pathway, while the Nanog-Nac1 interaction regulates cell cycle but not pluripotency.\",\n      \"method\": \"Gal4-DBD fusion co-immunoprecipitation, cell cycle analysis, Akt phosphorylation assay, luciferase reporter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in one study but single lab\",\n      \"pmids\": [\"19366700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of the human Nac1 POZ domain at 2.1 Å resolution shows it crystallizes as a dimer with interaction interfaces resembling POZ-zinc finger transcription factors; the C-terminal alpha-helix is shorter than most other POZ domains.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Acta crystallographica Section F\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure determination\",\n      \"pmids\": [\"19407373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NAC1 autophagy regulation is mediated by HMGB1: NAC1 increases HMGB1 expression, cytosolic translocation, and release; the resulting cytoplasmic HMGB1 activates autophagy; NAC1 knockdown or dominant-negative expression suppresses cisplatin-induced autophagy and increases cytotoxicity.\",\n      \"method\": \"siRNA knockdown, dominant-negative expression, Western blot, HMGB1 translocation imaging, autophagy inhibitors (3-MA, chloroquine), Beclin1/Atg5 siRNA\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological and genetic approaches converge on HMGB1-mediated autophagy pathway\",\n      \"pmids\": [\"21743489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NAC1 nuclear bodies undergo cell cycle-dependent dynamics: they increase in number and decrease in size in S phase, disappear during mitosis, and reappear after mitosis; FRAP shows rapid exchange of NAC1 between nucleoplasm and nuclear bodies in interphase.\",\n      \"method\": \"Fluorescence recovery after photobleaching (FRAP), live-cell imaging, cell cycle synchronization\",\n      \"journal\": \"Physical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging with FRAP, single lab\",\n      \"pmids\": [\"21301057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NAC1 functions as an actin monomer-binding protein via its BTB domain; disruption of NAC1 by dominant-negative or siRNA reduces cell retraction and abscission during cytokinesis, causing multinucleation; NAC1 modulates the binding of actin to profilin-1, and the NAC1/actin/profilin-1 complex is crucial for cancer cell cytokinesis.\",\n      \"method\": \"Actin-binding assay, siRNA knockdown, dominant-negative expression, rescue in Nac1-deficient murine fibroblasts, multinucleation phenotype quantification\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct actin binding demonstrated, genetic rescue experiment, multiple cell line validation\",\n      \"pmids\": [\"22761335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NAC1 nuclear localization requires a bipartite NLS in the N-terminal half of the protein that functions through the importin α/β pathway; dimer formation is not required for nuclear localization; the NLS is essential for NAC1's transcriptional regulatory function.\",\n      \"method\": \"Point mutagenesis, deletion mutant analysis, GFP-fusion nuclear import assay, Bimax1 peptide inhibitor of importin α/β pathway, importin binding assay\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis, pharmacological inhibition, and direct binding assay\",\n      \"pmids\": [\"22665369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss of NAC1 in Nacc1−/− mice causes vertebral patterning defects (L6 sacralization), reduced chondrocyte migratory potential, and decreased expression of matrilin-3 and matrilin-4, indicating NAC1 participates in chondrocyte motility and differentiation.\",\n      \"method\": \"Knockout mouse model, skeletal phenotyping, chondrocyte migration assay, immunostaining, gene expression analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with defined cellular and molecular phenotype\",\n      \"pmids\": [\"23922682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NAC1 regulates FOXQ1 expression: NAC1 knockdown decreases FOXQ1 promoter activity and transcript; ectopic NAC1 induces FOXQ1; constitutive FOXQ1 expression rescues cell motility after NAC1 silencing, placing FOXQ1 downstream of NAC1 in cell movement regulation.\",\n      \"method\": \"siRNA knockdown, ectopic expression, luciferase reporter (promoter activity), rescue experiment, transcriptome profiling\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain/loss of function with promoter assay and epistatic rescue\",\n      \"pmids\": [\"24200849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1 reveal the structural basis of POZ-domain heterodimer formation; Nac1 was identified as an interactor of Miz1 via POZ domain heterodimeric interaction, and Nac1 relocalizes Miz1 to NAC1 nuclear bodies; Nac1 siRNA knockdown increases p21Cip1 levels, consistent with relief of Miz1 inhibition.\",\n      \"method\": \"Chemical crosslinking, X-ray crystallography, co-immunoprecipitation, immunofluorescence, siRNA knockdown\",\n      \"journal\": \"Acta crystallographica Section F / Bioscience reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with functional validation by co-IP and siRNA knockdown\",\n      \"pmids\": [\"25484205\", \"24702277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nac1 coordinates ES cell differentiation by activating Oct4 and inhibiting both Sox2 and Tcf3; Nac1, Oct4, Tcf3, and Sox2 form a sub-network governing mesendodermal vs. neuroectodermal fate choice.\",\n      \"method\": \"Integrative gene expression analysis, quantitative constraints modeling, gain/loss of function in mESCs\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — integrative approach with functional validation, single lab\",\n      \"pmids\": [\"26832399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NAC1 promotes somatic cell reprogramming by facilitating NANOG binding to the E-cadherin promoter and by transcriptionally repressing ZEB1 (directly) and post-transcriptionally activating miR-200 miRNAs (indirectly) to upregulate E-cadherin expression.\",\n      \"method\": \"siRNA/shRNA knockdown, ChIP, promoter-reporter assay, miR-200 expression analysis, iPSC generation efficiency\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, reporter assay, and functional reprogramming readout with epistatic analysis\",\n      \"pmids\": [\"28781078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NAC1 overexpression drives drug resistance in colorectal cancer cells via induction of HOXA9 expression; knockdown of HOXA9 abrogates NAC1-induced resistance, establishing a NAC1→HOXA9 axis in chemoresistance.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, cell viability assay, caspase-3/7 activity\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — epistasis demonstrated but single lab and limited mechanistic depth\",\n      \"pmids\": [\"28713930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NAC1 mediates suppression of mitochondrial function in hypoxia through HIF-1α-induced expression of PDK3; NAC1-PDK3 axis inactivates pyruvate dehydrogenase and attenuates mitochondrial respiration, protecting cancer cells from apoptosis; re-expression of PDK3 in NAC1-absent cells rescues glycolysis.\",\n      \"method\": \"siRNA knockdown, ectopic expression, metabolic assays (glycolysis, oxygen consumption), xenograft model, qRT-PCR\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo rescue experiment with metabolic measurements\",\n      \"pmids\": [\"29163184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NAC1 forms a protein complex with CARM1 (identified by LC-MS/MS) in ovarian cancer cells; the NAC1 complex has an apparent molecular mass of 300-500 kDa (much larger than the 58 kDa monomer), indicating higher-order complex formation.\",\n      \"method\": \"FPLC size-exclusion chromatography, LC-MS/MS, co-immunoprecipitation, tissue microarray\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — MS identification with Co-IP confirmation, single lab\",\n      \"pmids\": [\"29983869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NAC1 bridges MAVS and TBK1 in the RLR antiviral signaling pathway: NAC1's BTB/POZ domain (aa 1-133) interacts with MAVS while the remaining portion binds TBK1; NAC1 promotes TBK1 recruitment to MAVS, enhancing TBK1 and IRF3 activation and IFN-β induction upon viral infection.\",\n      \"method\": \"Co-immunoprecipitation (overexpression and virus-induced), domain mapping, siRNA knockdown, overexpression with reporter assay, antiviral assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain mapping, functional Co-IP, reciprocal KD/OE with defined pathway placement\",\n      \"pmids\": [\"31235549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Met7 and Leu90 in NAC1's N-terminal domain (aa 1-130) are critical for homodimerization and stability; small molecule NIC3 selectively binds Leu-90, prevents homodimerization, and leads to proteasomal NAC1 degradation, sensitizing drug-resistant tumor cells to chemotherapy.\",\n      \"method\": \"Computational analysis, high-throughput screening, in vitro binding assay, site-directed mutagenesis, cell viability assay, xenograft model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of dimerization interface combined with HTS and in vivo validation\",\n      \"pmids\": [\"31101655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NAC1 interacts with Parkin and co-localizes with it in neurons; NAC1 overexpression promotes ubiquitin-dependent proteasomal degradation of Parkin, decreases proteasomal activity, and increases cellular susceptibility to proteasome inhibition-induced toxicity; POZ/BTB domain mutation Q23L disrupts NAC1-Parkin interaction.\",\n      \"method\": \"Co-immunoprecipitation, co-localization imaging, proteasome activity assay, mutagenesis, cell viability assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, mutagenesis, functional assay; single lab\",\n      \"pmids\": [\"24231739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NAC1 interacts with BCL6 via its C-terminal BEN domain; the NAC1-BCL6 complex binds the FOXQ1 promoter and activates FOXQ1 transcription; NAC1 also attenuates BCL6 negative autoregulation in ovarian cancer cells.\",\n      \"method\": \"Cistrome database analysis, ChIP, co-immunoprecipitation, luciferase reporter assay, microarray analysis\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and Co-IP with functional reporter, single lab\",\n      \"pmids\": [\"32412910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NAC1 is a negative regulator of FoxP3 in regulatory T cells (Tregs); NAC1−/− mice show increased CD4+ Tregs with higher FoxP3 acetylation and expression, slower FoxP3 turnover, and enhanced immune-suppressive activity; proinflammatory cytokines (IL-1β, TNF-α) induce NAC1 and decrease FoxP3.\",\n      \"method\": \"Knockout mouse model, flow cytometry, Treg functional assays, FoxP3 acetylation/stability measurements\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined molecular (FoxP3 acetylation) and cellular (Treg activity) readouts\",\n      \"pmids\": [\"35767626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tumorous expression of NAC1 positively regulates LDHA expression at the transcriptional level, increasing lactic acid accumulation in the tumor microenvironment, which inhibits cytokine production and induces exhaustion/apoptosis of CD8+ CTLs; NAC1-depleted tumors show elevated CTL infiltration.\",\n      \"method\": \"CRISPR/Cas9 NAC1 knockout, glycolysis analysis, retroviral transduction, flow cytometry, adoptive cell transfer in immunocompetent mice\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with in vivo adoptive transfer and defined molecular mechanism (LDHA/lactic acid)\",\n      \"pmids\": [\"36150745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NAC1 is a multi-SUMO-site acceptor; SUMOylation at K167, K318, K368, K483, and K498 does not alter NAC1 localization but facilitates NAC1 nuclear body formation; SUMO-site mutant NAC1 suppresses cell proliferation and tumor growth compared to wild-type NAC1.\",\n      \"method\": \"SUMO site mutagenesis, SUMOylation assay, immunofluorescence, cell proliferation assay, animal tumor model\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis with functional readout\",\n      \"pmids\": [\"36527749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NAC1 nuclear export is mediated by a nuclear export signal (NES) at aa 17-28; docetaxel treatment triggers nuclear-cytoplasmic shuttling of NAC1; cytoplasmic NAC1 binds cullin3 (Cul3) via its BTB domain and Cyclin B1 via its BOZ domain, forming an E3 ubiquitin ligase complex that ubiquitinates and degrades Cyclin B1, facilitating mitotic exit and docetaxel resistance.\",\n      \"method\": \"NES mapping, domain-specific binding assays, ubiquitination assay, Cyclin B1 degradation assay, NES-blocking peptide in vitro and in vivo\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain mapping, ubiquitination assay, in vitro/in vivo validation with NES-blocking peptide\",\n      \"pmids\": [\"37019189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NAC1 (Nacc1) R284W (human R298W) mutant impairs glutamatergic neurotransmission in a cell-autonomous, dominant-negative manner in autaptic mouse neurons; the mutant shows reduced binding to SynGAP1 and GluK2A, and greatly increased SUMOylation; ablating SUMOylation of Nacc1-R284W partially restores SynGAP1 binding. SynGAP1, GluK2A, and several SUMO E3 ligases were identified as novel Nacc1 interaction partners in the brain.\",\n      \"method\": \"Electrophysiology (autaptic neuron recordings), co-immunoprecipitation, SUMOylation assay, brain interactome screen\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiology with molecular mechanism (SUMOylation, binding partners) in disease-relevant mutant\",\n      \"pmids\": [\"37533751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In the Nacc1-R284W knock-in mouse model, the mutation causes epileptiform discharges, behavioral seizures, and altered synaptic gene expression (upregulation of postsynapse and ion channel genes); NACC1 nuclear immunoreactivity increases in cortical pyramidal neurons and parvalbumin interneurons, and levels of synaptic proteins are changed.\",\n      \"method\": \"Knock-in mouse model, EEG, behavioral testing, RNA-seq, immunohistochemistry, synaptic protein analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — engineered knock-in mouse with EEG, RNA-seq, and protein-level validation\",\n      \"pmids\": [\"38388424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NAC1 restrains CD4+ T-cell memory formation through the ROCK1-mediated autophagy pathway; NAC1-deficient CD4+ T cells have reduced ROCK1 expression, impaired BECLIN1 phosphorylation/stabilization, and defective autophagy; forced ROCK1 expression in NAC1−/− CD4+ T cells restores autophagy and abrogates enhanced memory formation.\",\n      \"method\": \"Knockout mouse model, adoptive transfer, viral infection model, ROCK1 overexpression rescue, AMPK-mTOR pathway analysis, autophagy flux assay\",\n      \"journal\": \"Journal of medical virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with rescue experiment and defined pathway placement\",\n      \"pmids\": [\"37465969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Treg-specific NAC1 deficiency upregulates FoxP3 expression and CD36-mediated lipid metabolism in Tregs, enhancing their metabolic fitness and immunosuppressive function in acidic tumor microenvironments; NAC1-deficient Tregs show enhanced tumoral infiltration and support tumor growth.\",\n      \"method\": \"Conditional Treg-specific NAC1 deletion, xenograft mouse models, adoptive Treg transfer, metabolic assays (lipid uptake, mitochondrial function)\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic metabolic studies with in vivo adoptive transfer; single lab\",\n      \"pmids\": [\"39773913\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NACC1 encodes a BTB/POZ-domain transcriptional co-repressor that homodimerizes (via BTB/POZ) and forms large nuclear complexes to repress target genes (including Gadd45GIP1, FOXQ1, ZEB1, and LDHA) by recruiting HDAC3/4 and CoREST; it also heterodimerizes with other POZ proteins (BCL6, Miz1, ZID, ZF5) and interacts with CARM1 and the pluripotency factor Nanog; in neurons it associates with the proteasome and mediates its recruitment to dendritic spines via a PKC-S245 phosphorylation-regulated nuclear-cytoplasmic shuttling mechanism; in cancer cells it acts as an actin-binding protein required for cytokinesis, undergoes nuclear export via an N-terminal NES to form a Cul3 E3 ligase complex that degrades Cyclin B1 and promotes taxane resistance, and is multi-SUMOylated to stabilize nuclear bodies; in immune cells it suppresses FoxP3 stability in Tregs, restrains CD8+ and CD4+ T-cell memory formation (via ROCK1/autophagy and IRF4 pathways), and bridges MAVS-TBK1 to potentiate antiviral type I IFN signaling; a recurrent de novo p.Arg298Trp mutation causes a neurodevelopmental syndrome by impairing glutamatergic neurotransmission, reducing SynGAP1/GluK2A binding, and increasing pathological SUMOylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NACC1 is a BTB/POZ-domain transcriptional co-repressor that homodimerizes to form dynamic nuclear bodies and recruits chromatin-modifying complexes—including HDAC3/4 and CoREST—to repress target genes such as Gadd45GIP1, FOXQ1, and ZEB1, while also heterodimerizing with other BTB/POZ proteins (BCL6, Miz1, ZID, ZF5) to modulate their transcriptional activities [PMID:10934270, PMID:16033423, PMID:17254023, PMID:25484205]. In neurons, NACC1 mediates activity-dependent recruitment of the proteasome to dendritic spines through PKC-dependent phosphorylation at S245 that governs its nuclear–cytoplasmic shuttling, and interacts with synaptic proteins SynGAP1 and GluK2A to support glutamatergic neurotransmission; a recurrent de novo R298W mutation causes a neurodevelopmental syndrome with epilepsy by disrupting these synaptic interactions and pathologically increasing SUMOylation [PMID:17699672, PMID:16045493, PMID:37533751, PMID:38388424]. In the immune system, NACC1 destabilizes FoxP3 in regulatory T cells, restrains CD4+ and CD8+ T-cell memory formation via ROCK1/autophagy signaling, and bridges MAVS to TBK1 to potentiate type I interferon responses during viral infection [PMID:35767626, PMID:37465969, PMID:31235549]. In cancer cells, cytoplasmic NACC1 assembles a Cul3-based E3 ubiquitin ligase that degrades Cyclin B1 to promote mitotic exit and taxane resistance, and its multi-site SUMOylation stabilizes nuclear bodies required for proliferation [PMID:37019189, PMID:36527749].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying NACC1 as a cocaine-regulated POZ/BTB-domain gene in the nucleus accumbens established its neural expression and domain architecture, opening the question of its molecular function.\",\n      \"evidence\": \"cDNA cloning with in situ hybridization and Northern blot in rat brain after cocaine self-administration\",\n      \"pmids\": [\"9278521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No function assigned beyond expression pattern\", \"POZ domain role uncharacterized\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that NAC1 represses transcription via its POZ domain and that overexpression blocks cocaine sensitization established it as a nuclear transcriptional repressor with behavioral relevance.\",\n      \"evidence\": \"Gal4-luciferase reporter assay, mammalian two-hybrid, adenoviral overexpression in rat nucleus accumbens\",\n      \"pmids\": [\"10934270\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor recruitment mechanism unknown\", \"Direct DNA-binding capacity unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of HDAC3/4 and CoREST as direct NAC1 partners, and PKC-S245 phosphorylation as a switch for nuclear-cytoplasmic distribution, defined the enzymatic basis of NAC1-mediated repression and its activity-dependent regulation in neurons.\",\n      \"evidence\": \"Co-IP, GST pulldown, HDAC inhibitor rescue of reporter repression; PKC-site mutagenesis with immunofluorescence in primary neurons\",\n      \"pmids\": [\"16033423\", \"16045493\", \"17254023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct genomic targets of NAC1 repression not yet mapped\", \"Whether HDAC3 vs. HDAC4 recruitment is context-specific\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that NAC1 recruits the proteasome to dendritic spines in an activity-dependent manner, and that it represses Gadd45GIP1 to sustain cancer cell growth, revealed dual cytoplasmic and nuclear effector functions.\",\n      \"evidence\": \"Co-IP of NAC1 with proteasome subunits, Nac1 KO neurons lacking spine proteasome recruitment; SAGE-based target identification with siRNA/ectopic expression in cancer cells\",\n      \"pmids\": [\"17699672\", \"17804717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of proteasome cargo recognition by NAC1 unclear\", \"Whether Gadd45GIP1 is a direct transcriptional target not resolved by ChIP\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structure of the NAC1 POZ domain at 2.1 Å confirmed dimeric architecture, while functional studies showed homodimerization is essential for paclitaxel resistance via the Gadd45 pathway and that NAC1 interacts with Nanog to regulate ES cell proliferation.\",\n      \"evidence\": \"X-ray crystallography; dominant-negative disruption of homodimerization with chemosensitivity assays; Nanog-NAC1 co-IP with ERas/PI3K pathway readouts\",\n      \"pmids\": [\"19407373\", \"19305429\", \"19366700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NAC1 transitions between transcription factor and ES cell pluripotency roles\", \"No co-crystal with DNA or HDAC partners\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of NAC1 as an actin monomer-binding protein required for cytokinesis, and mapping of its bipartite NLS, revealed a structural role in cell division beyond transcriptional repression.\",\n      \"evidence\": \"Direct actin-binding assay, multinucleation phenotype upon NAC1 loss, rescue in Nac1-null fibroblasts; NLS mutagenesis with importin pathway inhibition\",\n      \"pmids\": [\"22761335\", \"22665369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether actin binding and transcriptional repression are separable functions in vivo\", \"Structural basis of actin-BTB domain interaction unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystal structures of NAC1-Miz1 and BCL6-Miz1 POZ heterodimers defined the structural basis for NAC1 heterodimerization and showed that NAC1 sequesters Miz1 into nuclear bodies to relieve p21 repression.\",\n      \"evidence\": \"X-ray crystallography of heterodimeric POZ complexes, co-IP, siRNA knockdown of NAC1 increasing p21\",\n      \"pmids\": [\"25484205\", \"24702277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of POZ heterodimer partners in vivo not defined\", \"Genome-wide transcriptional consequences of Miz1 sequestration unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NAC1 was shown to bridge MAVS and TBK1 via distinct domains to potentiate type I IFN signaling, establishing an innate immune function; separately, critical dimerization residues (Met7, Leu90) were mapped and targeted by the small molecule NIC3.\",\n      \"evidence\": \"Domain-mapping co-IP with viral infection; HTS identifying NIC3, mutagenesis of Leu90, xenograft chemosensitization\",\n      \"pmids\": [\"31235549\", \"31101655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NAC1's antiviral role operates in vivo during natural infection\", \"Pharmacokinetics and selectivity of NIC3 in vivo\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genetic studies in Nacc1−/− mice revealed NAC1 as a negative regulator of FoxP3 stability in Tregs and of LDHA-driven lactic acid production in tumors, linking NAC1 to adaptive immune regulation and tumor immune evasion.\",\n      \"evidence\": \"Knockout mouse with FoxP3 acetylation/stability assays; CRISPR KO with adoptive T-cell transfer in immunocompetent mice\",\n      \"pmids\": [\"35767626\", \"36150745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism by which NAC1 promotes FoxP3 deacetylation not identified\", \"Whether LDHA is a direct transcriptional target confirmed by ChIP\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematic SUMO-site mutagenesis showed that multi-site SUMOylation facilitates NAC1 nuclear body formation and is required for its pro-proliferative activity, adding a post-translational layer to nuclear body regulation.\",\n      \"evidence\": \"Mutagenesis of five SUMO sites, SUMOylation assay, nuclear body imaging, tumor growth assay\",\n      \"pmids\": [\"36527749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of SUMO E3 ligases acting on NAC1 in cancer cells not defined\", \"Whether SUMOylation modulates specific transcriptional targets\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapping of an N-terminal NES and demonstration that cytoplasmic NAC1 forms a Cul3 E3 ligase targeting Cyclin B1 for degradation explained how NAC1 promotes mitotic exit and taxane resistance, unifying its nuclear export and ubiquitin ligase activities.\",\n      \"evidence\": \"NES mapping, ubiquitination assay, Cyclin B1 degradation kinetics, NES-blocking peptide in xenograft\",\n      \"pmids\": [\"37019189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Cyclin B1 is the sole Cul3-NAC1 substrate\", \"How NES-mediated export is triggered specifically by taxanes\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The recurrent R298W mutation was shown to impair glutamatergic neurotransmission cell-autonomously by reducing SynGAP1/GluK2A binding and increasing pathological SUMOylation, providing a molecular mechanism for the associated neurodevelopmental syndrome.\",\n      \"evidence\": \"Autaptic neuron electrophysiology, co-IP of mutant vs. wild-type interactomes, SUMOylation assays with rescue\",\n      \"pmids\": [\"37533751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SUMOylation-ablated R298W fully rescues synaptic function in vivo\", \"Which SUMO E3 ligase(s) preferentially modify the mutant\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A Nacc1-R284W knock-in mouse recapitulated epilepsy with altered synaptic gene networks, validating the mutation as causal for the human neurodevelopmental phenotype and revealing compensatory transcriptional changes.\",\n      \"evidence\": \"Knock-in mouse with EEG, behavioral seizure scoring, RNA-seq, immunohistochemistry\",\n      \"pmids\": [\"38388424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether seizures arise from excitatory neuron, interneuron, or circuit-level dysfunction\", \"Therapeutic targets within the dysregulated synaptic gene network not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the genome-wide direct target repertoire of NAC1 (by ChIP-seq), the structural basis of NAC1's interactions with non-POZ partners (HDAC3/4, proteasome, SynGAP1), how SUMOylation versus phosphorylation coordinately regulate NAC1 function in different cell types, and the full substrate spectrum of the Cul3-NAC1 E3 ligase.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide ChIP-seq for direct NAC1 binding sites published\", \"No structure of NAC1 in complex with HDAC, proteasome, or synaptic partners\", \"Interplay between SUMOylation and S245 phosphorylation not studied\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 4, 7, 9, 19, 22]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [26, 33]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 6, 15, 17]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 33]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 4, 7, 9, 19, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [26, 30, 31, 36, 37]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [15, 16, 33]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [14, 36]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [33, 28]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 11]}\n    ],\n    \"complexes\": [\n      \"CoREST complex\",\n      \"Cul3 E3 ubiquitin ligase complex\"\n    ],\n    \"partners\": [\n      \"HDAC3\",\n      \"HDAC4\",\n      \"RCOR1\",\n      \"BCL6\",\n      \"ZBTB17\",\n      \"CUL3\",\n      \"MAVS\",\n      \"TBK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}